Published in Curr Opin Rheumatol on September 01, 2013
Salivary gland diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.91
The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity. Cytokine Growth Factor Rev (2014) 0.79
American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) (2012) 4.82
Treatment of primary Sjögren syndrome: a systematic review. JAMA (2010) 2.37
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. Ann Rheum Dis (2012) 2.28
Enhanced apoptosis by disruption of the STAT3-IκB-ζ signaling pathway in epithelial cells induces Sjögren's syndrome-like autoimmune disease. Immunity (2013) 1.65
STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease, Sjogren's syndrome. Proc Natl Acad Sci U S A (2012) 1.55
Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjögren's syndrome patients is linked to ectopic mucin secretion. J Autoimmun (2012) 1.43
Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry. Clin Exp Rheumatol (2012) 1.42
Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun (2009) 1.39
Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (2012) 1.38
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood (2012) 1.27
Novel autoantibodies in Sjogren's syndrome. Clin Immunol (2012) 1.20
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis (2012) 1.16
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci U S A (2012) 1.10
Genetics of Sjögren's syndrome in the genome-wide association era. J Autoimmun (2012) 1.01
Primary Sjögren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol (1999) 1.00
High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjögren syndrome. Ann Rheum Dis (2008) 1.00
Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol (2012) 0.99
Primary Sjögren's syndrome in children and adolescents: are proposed diagnostic criteria applicable? J Rheumatol (2005) 0.99
Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren's syndrome. Oral Dis (2011) 0.97
Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients. Clin Exp Immunol (2012) 0.96
Sjögren's syndrome and the epithelial target: a comprehensive review. J Autoimmun (2013) 0.96
Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome. Clin Exp Immunol (2012) 0.95
Type I interferons in Sjögren's syndrome. Autoimmun Rev (2012) 0.94
Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells. J Autoimmun (2013) 0.94
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis (2012) 0.93
Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Arthritis Res Ther (2012) 0.92
The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome. Clin Exp Rheumatol (2012) 0.92
Recurrent parotitis as a presentation of primary pediatric Sjögren syndrome. Pediatrics (2011) 0.91
The role of ectopic germinal centers in the immunopathology of primary Sjögren's syndrome: a systematic review. Semin Arthritis Rheum (2012) 0.91
Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy. Arthritis Res Ther (2012) 0.90
Type I interferon receptor deficiency prevents murine Sjogren's syndrome. J Dent Res (2013) 0.90
Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples. Ann Rheum Dis (2012) 0.90
Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model. Arthritis Res Ther (2012) 0.89
Autoantibodies against muscarinic type 3 receptor in Sjögren's syndrome inhibit aquaporin 5 trafficking. PLoS One (2013) 0.89
In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev (2011) 0.89
Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors. Biochim Biophys Acta (2011) 0.87
Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis. Arthritis Rheum (2013) 0.86
Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome. Clin Exp Rheumatol (2012) 0.85
Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease. PLoS One (2012) 0.84
Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy. Ann Rheum Dis (2012) 0.84
Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor. Mod Rheumatol (2011) 0.84
Renal involvement in primary Sjogren syndrome of childhood: case report and literature review. Mod Rheumatol (2012) 0.84
Quantitative proteomics of parotid saliva in primary Sjögren's syndrome. Proteomics (2012) 0.79
Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome. Presse Med (2012) 0.78
BXSB/MpJ-Yaa mice develop autoimmune dacryoadenitis with the appearance of inflammatory cell marker messenger RNAs in the lacrimal fluid. Clin Experiment Ophthalmol (2013) 0.78
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab. Ann Rheum Dis (2012) 0.78
The salivary gland epithelial cells of patients with primary Sjögren's syndrome manifest significantly reduced responsiveness to 17β-estradiol. J Autoimmun (2012) 0.78
Elevated immunoglobulin to tissue KLK11 in patients with Sjögren syndrome. Cornea (2013) 0.77
Anti-M(3) peptide IgG from Sjögren's syndrome triggers apoptosis in A253 cells. Cell Immunol (2012) 0.76
Carbonic anhydrase autoantibodies and sicca symptoms in primary Sjögren´s syndrome. Clin Exp Rheumatol (2012) 0.76
Decreased salivary sulphotransferase activity correlated with inflammation and autoimmunity parameters in Sjogren's syndrome patients. Rheumatology (Oxford) (2011) 0.76
Increased immune reactivity towards human hsp60 in patients with primary Sjögren's syndrome is associated with increased cytokine levels and glandular inflammation. Clin Exp Rheumatol (2012) 0.76